Skip to main content
. 2022 Jul 13;12:11876. doi: 10.1038/s41598-022-15293-5

Table 1.

Patient characteristics.

All (n = 8) ACPA+ ACPA+ ACPA− ACPA−
Subjects (N/gender) 7 F/1 M F F F F
Age (median/range) 70 (23–80) 70–75 45–50 70–75 60–65
CCP-titer (range/cut-off 3)

4 + (80–300)

4 − (< 0.5–0.5)

300  > 300  < 0.5 0.5
RF status (+/−) 4+/4−  +   + 
Tender joints, 28-count (median, range) 11 (8–16) 10 8 16 8
Swollen joints, 28-count (median, range) 10 (1–18) 16 7 14 11
Pain, global VAS (median, range) 75 (26–87) 87 50 84 83
CRP, mg/l (median, range) 14 (1–135) 81 4 14 135
ESR, mm (median, range) 49 (20–71) 44 36 56 71
DAS28-CRP (median, range) 5.4 (3.85–6.66) 6.66 4.56 6.4 6.4
DAS28-SR (median, range) 6.47 (5.07–7.28) 6.76 5.53 7.28 6.66
Time of biopsy (days after diagnosis) 2 (1–2) 2 2 2 2
Time of symptom (months before diagnosis) 6 (2–24) 24* 5.5 4 5

*This patient had knee pain 24 months prior to fulfilling an RA diagnosis that was ascribed as early knee arthrosis based on X-ray (no any alterations in small joints were found at this time point). She subsequently developed small joint arthritis 1 month prior to RA diagnosis.